Revvity (LTS:0KHE) Change In Receivables : $55 Mil (TTM As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Revvity Change In Receivables?

Revvity's change in receivables for the quarter that ended in Sep. 2024 was $5 Mil. It means Revvity's Accounts Receivable declined by $5 Mil from Jun. 2024 to Sep. 2024 .

Revvity's change in receivables for the fiscal year that ended in Dec. 2023 was $-9 Mil. It means Revvity's Accounts Receivable increased by $9 Mil from Dec. 2022 to Dec. 2023 .

Revvity's Accounts Receivable for the quarter that ended in Sep. 2024 was $602 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Revvity's Days Sales Outstanding for the three months ended in Sep. 2024 was 80.32.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Revvity's liquidation value for the three months ended in Sep. 2024 was $-2,964 Mil.

Revvity Change In Receivables Historical Data

The historical data trend for Revvity's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revvity Change In Receivables Chart

Revvity Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-100.63

-398.85

165.59

66.09

-9.00

Revvity Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Receivables	Get a 7-Day Free Trial															-20.70	21.92	37.19	-9.00	5.10

Revvity Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $55 Mil.

Revvity (LTS:0KHE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Revvity's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	602.141	/	684.049	*	91
=	80.32

2. In Ben Graham's calculation of liquidation value, Revvity's accounts receivable are only considered to be worth 75% of book value:

Revvity's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1229.778	-	4848.036	+	0.75 * 602.141	+	0.5 * 404.57
=	-2,964

Revvity Change In Receivables Related Terms

Thank you for viewing the detailed overview of Revvity's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Revvity Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Revvity Inc (LTS:0KHE) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

RVTY:USA PKN:Germany PKN:Germany R1VT34:Brazil

Address

940 Winter Street, Waltham, MA, USA, 02451

Website

https://www.revvity.com

Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.

Revvity Headlines

No Headlines